-
1
-
-
31444446505
-
Current therapy for Wilms’ tumor
-
Dome JS, Metzger ML. Current therapy for Wilms’ tumor. The Oncologist. 2005; 10: 815-826.
-
(2005)
The Oncologist.
, vol.10
, pp. 815-826
-
-
Dome, J.S.1
Metzger, M.L.2
-
2
-
-
4344642234
-
Treatment of relapsed Wilms’ tumor with high dose therapy and autologous hematopoietic stem cell rescue: The experience at Children’s Memorial Hospital
-
Campbell A, Cohn S, Reynolds M, et al. Treatment of relapsed Wilms’ tumor with high dose therapy and autologous hematopoietic stem cell rescue: the experience at Children’s Memorial Hospital. J Clin Oncol. 2004; 22: 2885-2890.
-
(2004)
J Clin Oncol.
, vol.22
, pp. 2885-2890
-
-
Campbell, A.1
Cohn, S.2
Reynolds, M.3
-
3
-
-
0021888070
-
Recurrence of Wilms’ tumor after apparent cure
-
Kim TH, Zaatari G, Baum ES, et al. Recurrence of Wilms’ tumor after apparent cure. J Pediatr. 1985; 107: 44-49.
-
(1985)
J Pediatr.
, vol.107
, pp. 44-49
-
-
Kim, T.H.1
Zaatari, G.2
Baum, E.S.3
-
4
-
-
37549055839
-
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
-
Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008; 50: 236-241.
-
(2008)
Pediatr Blood Cancer.
, vol.50
, pp. 236-241
-
-
Malogolowkin, M.1
Cotton, C.A.2
Green, D.M.3
-
7
-
-
0000498670
-
Wilms’ tumor: Its behavior and prognosis
-
Collins VP. Wilms’ tumor: its behavior and prognosis. J La State Med Soc. 1955; 107: 474-480.
-
(1955)
J La State Med Soc.
, vol.107
, pp. 474-480
-
-
Collins, V.P.1
-
8
-
-
28844480519
-
Collins’ law revisited: Can we reliably predict the time to recurrence in common pediatric tumors?
-
Paulino AC. Collins’ law revisited: can we reliably predict the time to recurrence in common pediatric tumors? Pediatr Hematol Oncol. 2006; 23: 81-86.
-
(2006)
Pediatr Hematol Oncol.
, vol.23
, pp. 81-86
-
-
Paulino, A.C.1
-
9
-
-
0024602789
-
Prognostic factors for children with recurrent Wilms’ tumor: Results from the second and third National Wilms’ tumor study
-
Grundy P, Breslow N, Green DM, et al. Prognostic factors for children with recurrent Wilms’ tumor: results from the second and third National Wilms’ tumor study. J Clin Oncol. 1989; 7: 638-647.
-
(1989)
J Clin Oncol.
, vol.7
, pp. 638-647
-
-
Grundy, P.1
Breslow, N.2
Green, D.M.3
-
10
-
-
31444451325
-
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms’ tumor: A report from the National Wilms’ tumor study group
-
Grundy P, Breslow N, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms’ tumor: a report from the National Wilms’ tumor study group. J Clin Oncol. 2005; 23: 7312-7321.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 7312-7321
-
-
Grundy, P.1
Breslow, N.2
Li, S.3
-
11
-
-
0031725726
-
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high risk recurrent Wilms’ tumor: A French Society of Pediatric Oncology Study
-
Pein F, Michon J, Valteau-Couanet V, et al. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high risk recurrent Wilms’ tumor: a French Society of Pediatric Oncology Study. J Clin Oncol. 1998; 16: 3295-3301.
-
(1998)
J Clin Oncol.
, vol.16
, pp. 3295-3301
-
-
Pein, F.1
Michon, J.2
Valteau-Couanet, V.3
-
12
-
-
0036018913
-
Ifosfamide, carboplatin, and etoposide in children with poor-risk relapsed Wilms’ Tumor: A Children’s Cancer Group report
-
Abu-Gosh AM, Krailo MD, Goldman SC, et al. Ifosfamide, carboplatin, and etoposide in children with poor-risk relapsed Wilms’ Tumor: a Children’s Cancer Group report. Ann Oncol. 2002; 13: 460-469.
-
(2002)
Ann Oncol.
, vol.13
, pp. 460-469
-
-
Abu-Gosh, A.M.1
Krailo, M.D.2
Goldman, S.C.3
-
13
-
-
0036952620
-
Nephroblastoma high dose chemotherapy with autologous stem cell rescue in children with nephroblastoma
-
Kremens B, Gruhn B, Klingebiel T, et al. Nephroblastoma high dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant. 2002; 30: 893-898.
-
(2002)
Bone Marrow Transplant.
, vol.30
, pp. 893-898
-
-
Kremens, B.1
Gruhn, B.2
Klingebiel, T.3
-
14
-
-
44149083336
-
Treatment of high-risk relapsed Wilms’ tumor with dose intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: Experience by the Italian Association of Pediatric Hematology and Oncology
-
Spreafico F, Bisogno G, Collini P, et al. Treatment of high-risk relapsed Wilms’ tumor with dose intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer. 2008; 51: 23-28.
-
(2008)
Pediatr Blood Cancer.
, vol.51
, pp. 23-28
-
-
Spreafico, F.1
Bisogno, G.2
Collini, P.3
|